Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes

Table 3

Adverse events in the exenatide and metformin groups.

Adverse events	Exenatide ()	Metformin ()
Major hypoglycemia, n (%)	0	0	1
Minor hypoglycemia, n (%)	5 (4.7%)	3 (2.5%)	0.481